Picard Medical is trading 7.84% down at $3.88, with no confirmed company-specific announcement or overnight catalyst explaining the September 22 move.
- The decline extends steep declines from September 17 through September 21.
- Available news listings show previously reported financial, financing, leadership, clinical-development, and NYSE compliance items rather than a new September 22 event.
- Broader markets are modestly higher, so macro sentiment does not clearly explain the decline.